Another study published recently by the group from Memorial Sloan Kettering Cancer Center (MSKCC)identified UBA1 mutations in 1% of MDS patients and inflammatory clinical presentation and vacuoles were observed in 83% and 71% respectively of patients with pathogenic UBA1 mutations [23]. Here, UBA1 is linked to myelodysplastic syndrome.